Resistance of prostate cancer cells to soluble TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) can be overcome by doxorubicin or adenoviral delivery of full-length TRAIL

Author:

Voelkel-Johnson Christina,King Deanne Lea,Norris James Scott

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Molecular Biology,Molecular Medicine

Reference37 articles.

1. Greenlee RT, Hill-Harmon MB, Murrey T, Thun M . Cancer Statistics 2001 CA 2001 51: 15–36

2. Ries LAG, Kosary CL, Hankey BF, Miller BA, Harras A, Edwards BK . SEER Cancer Statistics Review, 1973–1994 National Cancer Institute. NIH Publ. No. 97-2789. Bethesda, MD: US Dept. of Health and Human Services, Public Health Institute, National Institutes of Health, National Cancer Institute 1997

3. Steiner MS, Gingrich JR . Gene therapy for prostate cancer: where are we now? J Urol 2000 164: 1121–1136

4. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A . Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family J Biol Chem 1996 271: 12687–12690

5. Wiley SR, Schooley K, Smolak PJ et al. Identification and characterization of a new member of the TNF family that induces apoptosis Immunity 1995 3: 673–682

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3